Work

IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5 + B‐ and T‐cell trafficking to tumor‐conditioned media

Year: 2014

Type: article

Source: Immunology and Cell Biology

DOI: 10.1038/icb.2014.110

Authors: Erica Maria Pimenta, Saurav De, Ryan Weiss, Di Feng, Kelly Hall, Sarah Kilic, Gyan Bhanot, Shridar Ganesan, Sophia Ran, Betsy J Barnes

Institutions: Rutgers Health, Rutgers New Jersey Medical School, Boehringer Ingelheim (United States), SIU Medicine, Rutgers, The State University of New Jersey, Rutgers Cancer Institute

Language: English

Topic: Chemokine receptors and signaling

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, National Institutes of Health, National Cancer Institute, Congressionally Directed Medical Research Programs, European Microkelvin Platform, New Jersey Commission on Cancer Research

Awards: Interdisciplinary Training Program in Cancer Research, G8739934031

OpenAlex ID: W1995494870

FWCI: 1.005

Cites: 80

Cited by: 39

Related to: 10